DYSPORT for Injection AbobotulinumtoxinA Neurotoxin Clinical and Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD).
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms ANCHOR-CD
- Sponsors Ipsen
- 08 Jun 2017 Results (n=843) evaluating impact of injection interval on patient satisfaction using patient data from INTEREST IN CD2 & ANCHOR-CD trials, presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 15 Sep 2016 Data from this trial has been selected for presentation at the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM), as reported by Ipsen Biopharmaceuticals media release.
- 21 Apr 2016 Results (n=350) of abobotulinumtoxinA injection usage patterns in patients were presented at the 68th Annual Meeting of the American Academy of Neurology.